Cargando…

Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction

Persistent immune activation and inflammation in people living with HIV (PLWH) are associated with immunosenescence, premature aging and increased risk of non-AIDS comorbidities, with the underlying mechanisms not fully understood. In this study, we show that downregulation of the T-cell immunoglobu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunet, Rémi, Nayrac, Manon, Ramani, Hardik, Sylla, Mohamed, Durand, Madeleine, Chartrand-Lefebvre, Carl, Routy, Jean-Pierre, Landay, Alan L., Gauchat, Jean-Francois, Chomont, Nicolas, Ancuta, Petronela, Kaufmann, Daniel E., Bernard, Nicole, Tremblay, Cécile L., El-Far, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190400/
https://www.ncbi.nlm.nih.gov/pubmed/34122431
http://dx.doi.org/10.3389/fimmu.2021.673061
_version_ 1783705679830188032
author Bunet, Rémi
Nayrac, Manon
Ramani, Hardik
Sylla, Mohamed
Durand, Madeleine
Chartrand-Lefebvre, Carl
Routy, Jean-Pierre
Landay, Alan L.
Gauchat, Jean-Francois
Chomont, Nicolas
Ancuta, Petronela
Kaufmann, Daniel E.
Bernard, Nicole
Tremblay, Cécile L.
El-Far, Mohamed
author_facet Bunet, Rémi
Nayrac, Manon
Ramani, Hardik
Sylla, Mohamed
Durand, Madeleine
Chartrand-Lefebvre, Carl
Routy, Jean-Pierre
Landay, Alan L.
Gauchat, Jean-Francois
Chomont, Nicolas
Ancuta, Petronela
Kaufmann, Daniel E.
Bernard, Nicole
Tremblay, Cécile L.
El-Far, Mohamed
author_sort Bunet, Rémi
collection PubMed
description Persistent immune activation and inflammation in people living with HIV (PLWH) are associated with immunosenescence, premature aging and increased risk of non-AIDS comorbidities, with the underlying mechanisms not fully understood. In this study, we show that downregulation of the T-cell immunoglobulin receptor CD96 on CD8(+) T cells from PLWH is associated with decreased expression of the co-stimulatory receptors CD27 and CD28, higher expression of the senescence marker CD57 and accumulation of a terminally differentiated T-cell memory phenotype. In addition, we show that CD96-low CD8(+) T-cells display lower proliferative potential compared to their CD96-high counterparts and that loss of CD96 expression by HIV-specific CD8(+) T-cells is associated with a suboptimal response to HIV antigens. In conclusion, our results suggest that CD96 marks CD8(+) T-cells with competent responses to HIV and the loss of its expression might be used as a biomarker for CD8(+) T-cell senescence and dysfunction in PLWH.
format Online
Article
Text
id pubmed-8190400
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81904002021-06-11 Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction Bunet, Rémi Nayrac, Manon Ramani, Hardik Sylla, Mohamed Durand, Madeleine Chartrand-Lefebvre, Carl Routy, Jean-Pierre Landay, Alan L. Gauchat, Jean-Francois Chomont, Nicolas Ancuta, Petronela Kaufmann, Daniel E. Bernard, Nicole Tremblay, Cécile L. El-Far, Mohamed Front Immunol Immunology Persistent immune activation and inflammation in people living with HIV (PLWH) are associated with immunosenescence, premature aging and increased risk of non-AIDS comorbidities, with the underlying mechanisms not fully understood. In this study, we show that downregulation of the T-cell immunoglobulin receptor CD96 on CD8(+) T cells from PLWH is associated with decreased expression of the co-stimulatory receptors CD27 and CD28, higher expression of the senescence marker CD57 and accumulation of a terminally differentiated T-cell memory phenotype. In addition, we show that CD96-low CD8(+) T-cells display lower proliferative potential compared to their CD96-high counterparts and that loss of CD96 expression by HIV-specific CD8(+) T-cells is associated with a suboptimal response to HIV antigens. In conclusion, our results suggest that CD96 marks CD8(+) T-cells with competent responses to HIV and the loss of its expression might be used as a biomarker for CD8(+) T-cell senescence and dysfunction in PLWH. Frontiers Media S.A. 2021-05-27 /pmc/articles/PMC8190400/ /pubmed/34122431 http://dx.doi.org/10.3389/fimmu.2021.673061 Text en Copyright © 2021 Bunet, Nayrac, Ramani, Sylla, Durand, Chartrand-Lefebvre, Routy, Landay, Gauchat, Chomont, Ancuta, Kaufmann, Bernard, Tremblay and El-Far https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bunet, Rémi
Nayrac, Manon
Ramani, Hardik
Sylla, Mohamed
Durand, Madeleine
Chartrand-Lefebvre, Carl
Routy, Jean-Pierre
Landay, Alan L.
Gauchat, Jean-Francois
Chomont, Nicolas
Ancuta, Petronela
Kaufmann, Daniel E.
Bernard, Nicole
Tremblay, Cécile L.
El-Far, Mohamed
Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
title Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
title_full Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
title_fullStr Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
title_full_unstemmed Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
title_short Loss of CD96 Expression as a Marker of HIV-Specific CD8(+) T-Cell Differentiation and Dysfunction
title_sort loss of cd96 expression as a marker of hiv-specific cd8(+) t-cell differentiation and dysfunction
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190400/
https://www.ncbi.nlm.nih.gov/pubmed/34122431
http://dx.doi.org/10.3389/fimmu.2021.673061
work_keys_str_mv AT bunetremi lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT nayracmanon lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT ramanihardik lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT syllamohamed lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT durandmadeleine lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT chartrandlefebvrecarl lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT routyjeanpierre lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT landayalanl lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT gauchatjeanfrancois lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT chomontnicolas lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT ancutapetronela lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT kaufmanndaniele lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT bernardnicole lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT tremblaycecilel lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction
AT elfarmohamed lossofcd96expressionasamarkerofhivspecificcd8tcelldifferentiationanddysfunction